- Report
- March 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- October 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- August 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,298USD£3,157GBP
- Report
- July 2025
- 226 Pages
Global
From €3881EUR$4,450USD£3,383GBP
- Report
- September 2025
- 72 Pages
Global
From €3500EUR$4,298USD£3,157GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,298USD£3,157GBP
- Report
- November 2025
- 160 Pages
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- September 2025
- 135 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- September 2025
- 135 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- July 2025
- 140 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- July 2025
- 150 Pages
United States
From €5190EUR$5,950USD£4,523GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3375EUR$3,869USD£2,941GBP
- Report
- June 2025
- 90 Pages
United States
From €4230EUR$4,850USD£3,687GBP
- Report
- September 2023
- 303 Pages
Global
From €4691EUR$5,566USD£3,950GBP
- Report
- February 2024
- 202 Pages
Global
From €4361EUR$5,000USD£3,801GBP
- Report
- August 2023
- 115 Pages
Global
From €1963EUR$2,250USD£1,710GBP
- Report
- August 2025
- 200 Pages
Saudi Arabia
From €2172EUR$2,490USD£1,893GBP
- Report
- August 2023
- 370 Pages
Global
From €2172EUR$2,490USD£1,893GBP
- Report
- July 2023
- 210 Pages
Global
From €1736EUR$1,990USD£1,513GBP

The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more